Take Action: Let Congress Hear Your Voice on LDTs
The Food and Drug Administration (FDA) has proposed potentially crippling regulations on laboratory-developed tests (LDTs) affecting clinical microbiology laboratories and the patients they serve. The proposed rule phases out enforcement discretion for all LDTs and regulates them as medical devices, requiring labs to go through a lengthy and costly approval process for  LDTs.  

On Thursday, March 21, the Health Subcommittee of the House Energy and Commerce Committee held a hearing to discuss the new proposed rule. Tell Congress how these new regulations will affect your work and its impact on patients. Please take a moment to send a letter to your Representative and Senators. The pre-written letter we have provided can be customized with your personal story and sent to your elected officials today.  

For more information, you can read Dr. Linoj Samuel and Dr. Erin Graf's op-ed on how the proposed LDTs rule threatens outbreak containment. 

Guidelines: Please customize our prepared letter to send to your elected officials.     

    Message Body
    Suggested Message
    Remaining: 0
  • Hide
    • Please call this number:

      Please do not close this window. You will need to come back to this window to enter your code.
      We just sent an email to ... containing a verification code.

      If you do not see the email within the next five minutes, please ensure you entered the correct email address and check your spam/junk mail folder.
      Enter Your Info
      Your Information
      Home Information

      Enter Your Info